Last reviewed · How we verify
Virac Rex (undecoylium chloride iodine)
Virac Rex (generic name: undecoylium chloride iodine) is a drug developed by Chesebrough Ponds. It is currently FDA-approved.
Lapyrium chloride, also known as lapirium chloride, is a cationic surfactant used in personal care products as a biocide and antistatic agent. It is also used in waste-water treatment and corrosion inhibition formulations.
At a glance
| Generic name | undecoylium chloride iodine |
|---|---|
| Sponsor | Chesebrough Ponds |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Virac Rex CI brief — competitive landscape report
- Virac Rex updates RSS · CI watch RSS
- Chesebrough Ponds portfolio CI
Frequently asked questions about Virac Rex
What is Virac Rex?
Virac Rex (undecoylium chloride iodine) is a pharmaceutical drug developed by Chesebrough Ponds.
Who makes Virac Rex?
Virac Rex is developed and marketed by Chesebrough Ponds (see full Chesebrough Ponds pipeline at /company/chesebrough-ponds).
What is the generic name of Virac Rex?
undecoylium chloride iodine is the generic (nonproprietary) name of Virac Rex.
What development phase is Virac Rex in?
Virac Rex is FDA-approved (marketed).
Related
- Manufacturer: Chesebrough Ponds — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing